1. High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1
   Zhu Liang et al, 2017, Oncotarget CrossRef
2. microRNA‐138 induces cell survival and reduces WNT/β‐catenin signaling of osteoarthritis chondrocytes through NEK2
   Weiling Xu et al, 2019, IUBMB Life CrossRef
3. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1
   Hai-Xiang Yu et al, 2019, Biomedicine & Pharmacotherapy CrossRef
4. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1
   Dengfeng Li et al, 2018, Molecular and Cellular Biochemistry CrossRef
5. MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells
   Bingxia Shi et al, 2019, Cellular & Molecular Biology Letters CrossRef
6. Spatiotemporal microRNA profile in peripheral nerve regeneration: miR-138 targets vimentin and inhibits Schwann cell migration and proliferation
   KimberlyM Rieger-Christ et al, 2018, Neural Regeneration Research CrossRef
7. MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway
   Jia Xu et al, 2021, Chemical and Pharmaceutical Bulletin CrossRef
8. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1
   Zaiting Ye et al, 2017, Oncology Reports CrossRef
9. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2
   Dongyi Zhu et al, 2019, Pathology - Research and Practice CrossRef
10. microRNA-138-5p as a Worse Prognosis Biomarker in Pediatric, Adolescent, and Young Adult Osteosarcoma
    Gabriela Molinari Roberto et al, 2020, Pathology & Oncology Research CrossRef
11. TGFβ1-induced down-regulation of microRNA-138 contributes to epithelial-mesenchymal transition in primary lung cancer cells
    Fang Zhang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
12. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
    Peng Wu et al, 2018, BMC Cancer CrossRef
13. MicroRNA‑138 inhibits SOX12 expression and the proliferation, invasion and migration of ovarian cancer cells
    Miaomiao Qu et al, 2018, Experimental and Therapeutic Medicine CrossRef
14. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC
    Huaqi Wang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
15. MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1
    Junyong Zhao et al, 2019, Biomedicine & Pharmacotherapy CrossRef
16. Upregulation of miR-93 and inhibition of LIMK1 improve ventricular remodeling and alleviate cardiac dysfunction in rats with chronic heart failure by inhibiting RhoA/ROCK signaling pathway activation
    Qian Su et al, 2019, Aging CrossRef
17. Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention
    Sharmistha Dey et al, 2022, Medical Oncology CrossRef
18. MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
    Irina Fadejeva et al, 2017, Oncotarget CrossRef
19. Dasatinib Inhibits Lung Cancer Cell Growth and Patient Derived Tumor Growth in Mice by Targeting LIMK1
    Man Zhang et al, 2020, Frontiers in Cell and Developmental Biology CrossRef